WithdrawnPhase 2ketamine
Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy
Sponsored by Wake Forest University Health Sciences
NCT ID
NCT04939987
Start Date
2022-08
Est. Completion
2022-10
About This Study
This study will address the gaps in research of non-opioid postoperative pain management for prostatectomies.
Conditions Studied
Interventions
- •Tramadol
- •Gabapentin
- •Hydrocodone-Acetaminophen
- •Oxycodone-Acetaminophen
- •Ketorolac
- •Acetaminophen
- •Ketorolac tromethamine
- •Ketamine
Eligibility
Sex:MALE
Age:40 Years - 75 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * All men ages 40-75 undergoing bilateral robot assisted radical prostatectomy (RARP) with bilateral lymph node dissection with low-intermediate to high-risk localized prostate cancer Exclusion Criteria: * Allergies to any medication involved in the study * T4 prostate cancer * incarcerated persons * chronic narcotic dependence * any current prescription for narcotics * any surgery in the past 6 months
Study Locations (1)
Wake Forest Health Sciences
Winston-Salem, North Carolina, United States